The Effect of Atorvastatin on Beta-Cell Function

Summary

Atorvastatin therapy may delay the loss of beta-cell function in patients with recent-onset type 1 diabetes mellitus. This article discusses the multicenter, randomized, placebo-controlled Diabetes and Atorvastatin [DIATOR] trial.

  • Lipid Disorders
  • Diabetes & Endocrinology Clinical Trials
  • Diabetes Mellitus
View Full Text